Impact of Feeding and Medical Practices on the Development of Necrotizing Enterocolitis

Montenegro, Brian L.; Martin, Camilia R.

doi:10.1007/s40124-014-0061-9

Cited by 1 publication

(1 citation statement)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For preterm children with various immaturely developed systems, how to solve the conflict between the high nutritional demands and low gastrointestinal tolerability of preterm children is a very realistic and important issue. Therefore, we need an appropriate early enteral nutrition management strategy for preterm children, although there is already a lot of consensus [ 14 , 15 ], such as breastfeeding, initiation of microfeeding as early as possible, achieving full enteral nutrition as soon as possible, and shortening the time of parenteral nutrition in order to reduce complications. It is preferred to feed preterm children with their mothers’ breast milk [ 14 ], because such feeding can reduce the incidence of feeding intolerance, neonatal necrotizing enterocolitis (NEC), nosocomial infections, and growth and developmental retardation in preterm children [ 16 ].…”

Section: Introductionmentioning

confidence: 99%

Application effect of extensively hydrolyzed milk protein formula and follow-up in preterm children with a gestational age of less than 34 weeks: study protocol for a randomized controlled trial

Qian

Zhu

et al. 2015

Trials

View full text Add to dashboard Cite

BackgroundThe average incidence of preterm birth in the world is up to 11.1 %, and deaths of preterm children account for more than 50 % of neonatal deaths. Gastrointestinal function of preterm children with a gestational age less than 34 weeks is immaturely developed. For preterm children who can only be fed with formula due to their mothers’ sickness, choosing a suitable formula can not only meet the high nutritional needs of preterm children, but also solve their low gastrointestinal tolerability, and is thus very important.Methods/DesignThe study is a prospective, randomized, single-blind and controlled clinical trial. Preterm children with a gestational age less than 34 weeks meeting the inclusion criteria who cannot be breastfed will be included. To demonstrate the application effect of extensively hydrolyzed milk protein formula on the target population, preterm children will be randomized into two groups, 185 subjects in each group. The observation group will be fed with extensively hydrolyzed milk protein (100 % whey protein) formula, while the control group will be fed with preterm children’s formula until the children are discharged from the neonatal intensive care unit (NICU). All the formula involved in this study will be from Dumex. After discharge, both groups will be uniformly fed with formula for 0 to 6-month-old infants. For statistical analysis, a chi-square test and Student’s t test will be applied using SAS 9.4.DiscussionThis will be the first randomized controlled clinical study with long-term observation of the growth and development of preterm children during the NICU stay and at 3-month follow-up after discharge from the NICU. Results from this study will be used to determine whether the extensively hydrolyzed formula is more suitable for the low gastrointestinal tolerability of preterm children, and also whether feeding preterm children who are fed with such formula during the NICU stay with ordinary infant formula after discharge from the NICU would affect the normal growth and development of preterm children in the early stage of their lives.Trial registrationThis study was registered with the Chinese Clinical Trial Registry (http://www.chictr.org.cn/) with number ChiCTR-IOR-14005696, on December 22, 2014.

show abstract